Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery  Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Slides:



Advertisements
Similar presentations
Characterization and Importance of Air Leak After Lobectomy
Advertisements

Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Contemporary Bloodletting in Cardiac Surgical Care
Amit Iyengar, Christopher N. Scipione, MD, Parth Sheth, Richard G
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S
Liver and Cardiac Function in the Long Term After Fontan Operation
Variation in Red Blood Cell Transfusion Practices During Cardiac Operations Among Centers in Maryland: Results From a State Quality-Improvement Collaborative 
Niv Ad, MD, Linda Henry, PhD, Sharon Hunt, MBA, Sari D. Holmes, PhD 
Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both?  Alessandro Vivacqua, MD, Colleen G. Koch, MD,
Trevor Williams, MD, MPH, Brian C
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Beyond the Aortic Root: Staged Open and Endovascular Repair of Arch and Descending Aorta in Patients With Connective Tissue Disorders  Eric E. Roselli,
James Edgerton, MD, Giovanni Filardo, PhD, MPH, William H
The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both?  Gabriel Loor, MD, Jeevanantham Rajeswaran, PhD, Liang Li, PhD, Joseph F.
Mitral Valve Surgery in the Adult Marfan Syndrome Patient
Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life  Janne J. Jokinen, MD, Anu K. Turpeinen,
Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes  Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.
Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Bruce W. Lytle, MD, Eugene H. Blackstone, MD, Joseph F
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava
Loretta Erhunmwunsee, MD, Brian C
Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,
Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery  Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.
Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients  Faraz Kerendi, MD, John D. Puskas,
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.
Transfusion Increases the Risk for Vasoplegia After Cardiac Operations
Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival  Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti,
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Effect of Intercurrent Operation and Cerebral Oxygenation on Developmental Trajectory in Congenital Heart Disease  George M. Hoffman, MD, Cheryl L. Brosig,
Trevor Williams, MD, MPH, Brian C
Incremental Value of Anemia in Cardiac Surgical Risk Prediction With the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II Model  Giuseppe.
Who Do You Say You Are? The Annals of Thoracic Surgery
The Relationship Between Hospital Surgical Case Volumes and Mortality Rates in Pediatric Cardiac Surgery: A National Sample, 1988–2005  Karl F. Welke,
Use of Amiodarone After Major Lung Resection
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Risks and Predictors of Blood Transfusion in Pediatric Patients Undergoing Open Heart Operations  Andrea Székely, MD, PhD, Zsuzsanna Cserép, MD, Erzsébet.
Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral?  Elliot Wakeam, MD, MPH, Joseph.
What Are the Odds? The Annals of Thoracic Surgery
Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma  Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.
Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L
Gregory M. Barker, MD, Sean M. O'Brien, PhD, Karl F
Primary Cardiac Sarcoma
David P. Mason, MD, Dale H. Marsh, MD, Joan M. Alster, MS, Sudish C
Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A
Editorial Board, January 2010
Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery  Fausto Biancari, MD, PhD, Eeva-Maija.
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Aaron J. Lindsay, MD, Meng Xu, MS, Daniel I. Sessler, MD, Eugene H
The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection  Mark K. Ferguson, MD, Megan Huisingh-Scheetz, MD, MPH, Katherine.
Current Assessment of Mortality Rates in Congenital Cardiac Surgery
Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD 
Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma  Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,
Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma  Marc de Perrot, MD, Karen McRae, MD, Masaki.
Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Interinstitutional Comparison of Risk-Adjusted Mortality and Length of Stay in Congenital Heart Surgery  William M. DeCampli, MD, PhD, Redmond P. Burke,
Kirk A. Caddell, MS, Christopher B. Komanapalli, MD, Matthew S
Incidence and Predictors of Postoperative Deep Vein Thrombosis in Cardiac Surgery in the Era of Aggressive Thromboprophylaxis  Thomas A. Schwann, MD,
Blood Transfusion and Infection After Cardiac Surgery
Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant  Ryan R. Davies, MD, Shylah Haldeman,
Michelle C. Ellis, MD, Theron A. Paugh, CCP, Timothy A
Lung Transplantation for Idiopathic Pulmonary Fibrosis
The Impact of New Technology on Cardiothoracic Surgical Practice
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation  Marat Fudim, MD, Mary E. Davis, MS,
Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery  David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,
Presentation transcript:

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery  Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang Li, PhD, Fawzy G. Estafanous, MD, Floyd D. Loop, MD, Eugene H. Blackstone, MD  The Annals of Thoracic Surgery  Volume 82, Issue 1, Pages 13-20 (July 2006) DOI: 10.1016/j.athoracsur.2005.07.075 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Frequency histogram of red blood cell (RBC) units transfused. The Annals of Thoracic Surgery 2006 82, 13-20DOI: (10.1016/j.athoracsur.2005.07.075) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Frequency histogram of platelet units transfused. The Annals of Thoracic Surgery 2006 82, 13-20DOI: (10.1016/j.athoracsur.2005.07.075) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Mirrored histogram displays nominally 6-month follow-up Duke Activity Status Index scores according to whether red blood cells had been transfused. (Blue bars = no blood transfusion; red bars = red blood cell transfusion.) The Annals of Thoracic Surgery 2006 82, 13-20DOI: (10.1016/j.athoracsur.2005.07.075) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Empiric probabilities of five grouped follow-up Duke Activity Status Index (DASI) groups at each number of packed red blood cell (RBC) units according to whether platelets were given (yes/no). The solid lines denote with platelet usage; the dashed lines represent no platelet usage. The Annals of Thoracic Surgery 2006 82, 13-20DOI: (10.1016/j.athoracsur.2005.07.075) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Relationship between increasing age, recipient of blood transfusion (solid black line) or not (gray line), and the probability of being in the highest follow-up Duke Activity Status Index (DASI) functional category (58.2) based on a low-risk patient and the equation represented by Table 4. The dotted lines represent 95% confidence intervals. The Annals of Thoracic Surgery 2006 82, 13-20DOI: (10.1016/j.athoracsur.2005.07.075) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions